Objective:To summarize excellent current research in the field of Bioinformatics and Translational Informatics with application in the health domain. Method: We provide a synopsis of the articles selected for the IMIA Yearbook 2014, from which we attempt to derive a synthetic overview of current and future activities in the field. A first step of selection was performed by querying MEDLINE with a list of MeSH descriptors completed by a list of terms adapted to the section. Each section editor evaluated independently the set of 1,851 articles and 15 articles were retained for peer-review. Results: The selection and evaluation process of this Yearbook's section on Bioinformatics and Translational Informatics yielded three excellent articles regarding data management and genome medicine. In the first article, the authors present VEST (Variant Effect Scoring Tool) which is a supervised machine learning tool for prioritizing variants found in exome sequencing projects that are more likely involved in human Mendelian diseases. In the second article, the authors show how to infer surnames of male individuals by crossing anonymous publicly available genomic data from the Y chromosome and public genealogy data banks. The third article presents a statistical framework called iCluster+ that can perform pattern discovery in integrated cancer genomic data. This framework was able to determine different tumor subtypes in colon cancer. Conclusions: The current research activities still attest the continuous convergence of Bioinformatics and Medical Informatics, with a focus this year on large-scale biological, genomic, and Electronic Health Records data. Indeed, there is a need for powerful tools for managing and interpreting complex data, but also a need for user-friendly tools developed for the clinicians in their daily practice. All the recent research and development efforts are contributing to the challenge of impacting clinically the results and even going towards a personalized medicine in the near future.
Introduction
As mentioned in the last year Yearbook [1] , main ongoing work in Bioinformatics and Translational Informatics are related to Genome Medicine i.e. the identification from data of genes and mutations underlying human diseases by pursuing the research "from bedside to bench" [2] . In fact, the availability of large-scale genomic data from NGS experiments allows the analysis of the disease-related biomolecular networks, which are expected to couple genotypes and disease phenotypes to determine the biological mechanisms of complex diseases. The research activities is also a special interest to the management of "Big Data": ongoing genomic tests keep on generating massive amounts of data and our connected world propose novel requirements on transforming healthcare from reactive and hospital-centered, to preventive, proactive, evidence-based, and personalized medicine [3] with a focus on well-being rather than disease. Typical high-throughput sequencing identifies 3 to 10 million variants per individual [4] , which requires in some Electronic Health Records (EHRs) 5 to 10GB storage. For instance, the 1000 Genome Project [5] has identified tens of millions of different genomic variants. As highlighted by Starren et al. [6] , the clinical impact of the variants is mostly unknown and thus necessitates systems that dynamically reanalyze and interpret stored static genomic results in the context of evolving knowledge and clinical findings. In parallel, several tools have been developed. For instance, the web server Huvariome [7] can help to distinguish true new genomic variations from known variations. The web portal canEvolve [8] is developed for facilitating meta-analysis of oncogenomics datasets with a central access that provides information extracted from 90 cancer genomic studies and several platforms. Other applications are dedicated to large-scale data. The GEnomes Management Application (GEM.app) [9] allows to annotate, manage, visualize, and analyze large genomic datasets (1,600 whole exomes from 50 phenotypes). PreDPI-Ki [10] is a web server developed to predict drug-target interactions for drug discovery. The CRAVAT web server [11] assists the search for gene diseases in large-scale exome sequencing studies (whole exome data for Mendelian disorders) with the help of the Variant Effect Scoring Tool (VEST) a supervised machine learning classifier. The clinical translation of the bioinformatics results to an individual patient, which is poised to personalize medicine, is one of the challenges of the field. To manage and represent complex data and relationships efficiently, Farley et al. [12] proposed the BioIntelligence Framework that relies on a NoSQL database [13] . The framework creates a hypergraph-like store of public knowledge and when combined with personal genome and patient information, it derives a personalized genome-based knowledge store for clinical translation and discovery research.
All these studies and sequencing projects produce huge amounts of data, as for instance the Sequence Read Archive [14] of the NCBI. Most of the datasets are publicly accessible, and this poses the problems of the confidentiality of the data and the reuse of the results of personal genomics out of the scope of the clinical translation or research. In their study, Gymrek et al. [15] demonstrate the feasibility to track back the identities of multiple participants in public sequencing projects. The authors show how to infer surnames of male individuals by crossing anonymous publicly available genomic data from the Y chromosome and public genealogy data banks. Therefore; the results of genomic tests may place the patient at several risks (discrimination, or stigmatization) and, as stated by Korf and Rehm, raising new ethical, legal, and social issues [16] .
Best Paper Selection
The best paper selection for the section Bioinformatics and Translational Informatics follows a generic method, commonly used in all sections of the IMIA Yearbook 2014. As in past years, the search was performed on MEDLINE. The Boolean query included MeSH descriptors related to the domain of computational biology and medical genetics with a restriction to international peer-reviewed journals. Only original research articles published in 2013 were considered; we excluded the publications types reviews, editorials, comments, letters to the editors, etc. We limited the search to the major MeSH descriptors to avoid a large set of articles and we completed it by non-MeSH terms searched on the titles and abstracts of the articles. However, there was no restriction on the top international peer-reviewed journals of the Bioinformatics and Translational Informatics section and Medicine (by using the 2012 Impact Factors). This year, the PubMed query yielded a set of 1,851 articles that were evaluated separately by each section editor (TL & LFS) using the BibReview tool [17] . BibReview takes into entry a PubMed file (in XML format) and shows all metadata for each article. A user can tag with the help of the interface, the articles as "Accepted", "Conflict" or "Reject" (on text, abstract or title). The results of several reviewers can be merged and the results can be filtered. A set of 41 articles was tagged "Accepted" by the section editors, from which 15 articles are selected for peer-review. As mentioned in the introduction, Genome Medicine and complex disease analysis characterize the field and the researches. Finally after evaluation three papers [11, 15, 
Conclusions and Outlook
The current research activities still attest the continuous convergence of Bioinformatics and Medical Informatics, with a focus this year on large-scale biologic, genomic, and Electronic Health Records datasets. There is a need for powerful tools for managing efficiently and interpreting complex data, but also a need for user-friendly tools developed for the clinicians in their daily practice (identifying gene cancer cells for therapy, inherited cancer risk, risk factors for rare and common diseases, personalizing the choice of drug and dosage, etc). The recent research and development efforts are contributing to the challenge of impacting the results clinically and even going towards personalized medicine in the near future. Some frameworks already allow this translation but other issues (legal or ethical) must be taken into consideration when treating personal genomic data. More and more genomic data are available on Internet. In this paper, the authors show how they recovered, with very high probability, surnames of individuals from anonymous genomic data. For that they crossed data from highly polymorphic short tandem repeats on the Y chromosome with genetic genealogy databases in the United States of America that contain a large number of surname-haplotype records and they also performed Internet searches. This study only relies on publicly accessible Internet resources. The authors show that this can be done with Next Generation Sequencing data even at low coverage. The re-identification of a single person takes only a few hours. This surname inference from personal genomes questions the privacy of de-identified public data sets.
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In the last few years, there were considerable efforts for collecting genomic data for many types of cancer. The next challenge is mining these enormous amounts of data to unravel the biological mechanisms at the origin of these cancers: for instance to identify the genes involved in the processes. One goal is to discover therapeutic targets. Unfortunately cancer genome alterations are highly heterogeneous. In this paper, the authors present a statistical framework named iCluster+ that integrates diverse discrete and continuous genomic, epigenomic, and transcriptomic data related to cancers. This constitutes a significant enhancement of the iCluster method. This new method can perform pattern discovery using somatic mutations, copy number variations, and gene expression. It uses a linear regression with a set of latent variables that represent distinct biological factors. Using data from the Cancer Cell Line Encyclopedia and The Cancer Genome Atlas, this method was able to reveal distinct tumor subtypes in colon cancer.
